Novartis says flu vaccine US interim data shows lower doses of antigen may suffice to generate a protective immune response against A(H1N1)
Thursday, November 19, 2009 11:00 IST Basel
Novartis announced new interim data from ongoing clinical trials demonstrating that a single 7.5µg dose of the company's influenza A(H1N1) 2009 unadjuvanted vaccine
